个人中心 - 老虎社区

ArigatoMoney

IP属地：未知

帖子 · 14帖子 · 14
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- ArigatoMoneyArigatoMoney
  ·2021-12-17
  $JW THERAP-B(02126)$Bought at the right time… going up…..
  1,032 评论
  点赞
  分享
  举报
- ArigatoMoneyArigatoMoney
  ·2021-12-17
  $Genscript Biotech(01548)$Wooha!!
  2,519 评论
  点赞
  分享
  举报
- ArigatoMoneyArigatoMoney
  ·2021-12-17
  $Verizon(VZ)$Starting to increase. After a 2 weeks wait.
  1,053 评论
  1
  分享
  举报
- ArigatoMoneyArigatoMoney
  ·2021-10-30
  $Carnival(CCL)$go go go…
  769 评论
  1
  分享
  举报
- ArigatoMoneyArigatoMoney
  ·2021-09-27
  $fuboTV Inc.(FUBO)$Go go go!
  962 1
  3
  分享
  举报
- ArigatoMoneyArigatoMoney
  ·2021-09-10
  [Miser]
  706 评论
  1
  分享
  举报
- ArigatoMoneyArigatoMoney
  ·2021-08-24
  $Adamis Pharmaceuticals(ADMP)$A friend recommended saying this may be good to buy now, and if FDA approves this home medication, it might increase. Bought it last friday. Any thoughts?
  1,618 2
  5
  分享
  举报
- ArigatoMoneyArigatoMoney
  ·2021-08-24
  Tempol a home covid medication that is on clinical trial, yet to be approved for use. Any thoughts?
  946 评论
  1
  分享
  举报
- ArigatoMoneyArigatoMoney
  ·2021-08-24
  Advise for US stocks
  https://youtube.com/channel/UC6hhtmnety48C4IbUo2GKWAThis guy is very good and give very good advise on stocks. He updates on a daily basis.
  1,090 评论
  1
  分享
  举报
  Advise for US stocks
- ArigatoMoneyArigatoMoney
  ·2021-08-06
  Now dropping… 🤦🏻‍♀️
  Why COVID Vaccine Stocks Moderna, BioNTech, Novavax, and Dynavax Soared This Week
  Each vaccine stock had its own separate catalyst.
  Why COVID Vaccine Stocks Moderna, BioNTech, Novavax, and Dynavax Soared This Week
  773 评论
  2
  分享
  举报
暂无粉丝

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4088854238376920","uuid":"4088854238376920","gmtCreate":1625751176028,"gmtModify":1628068700039,"name":"ArigatoMoney","pinyin":"arigatomoney","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/7fdd63d4d735e78c6522c3b0ca49b71d","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":42,"tweetSize":14,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.56%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.22","exceedPercentage":"93.24%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":6,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":690442400,"gmtCreate":1639704873102,"gmtModify":1639704873102,"author":{"id":"4088854238376920","authorId":"4088854238376920","name":"ArigatoMoney","avatar":"https://static.tigerbbs.com/7fdd63d4d735e78c6522c3b0ca49b71d","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088854238376920","authorIdStr":"4088854238376920"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02126\">$JW THERAP-B(02126)$</a>Bought at the right time… going up…..","listText":"<a href=\"https://laohu8.com/S/02126\">$JW THERAP-B(02126)$</a>Bought at the right time… going up…..","text":"$JW THERAP-B(02126)$Bought at the right time… going up…..","images":[{"img":"https://static.tigerbbs.com/f821c1a6a4866102eaa4f4aa33041be1","width":"1242","height":"1968"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690442400","isVote":1,"tweetType":1,"viewCount":1032,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":690446344,"gmtCreate":1639704739619,"gmtModify":1639704739619,"author":{"id":"4088854238376920","authorId":"4088854238376920","name":"ArigatoMoney","avatar":"https://static.tigerbbs.com/7fdd63d4d735e78c6522c3b0ca49b71d","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088854238376920","authorIdStr":"4088854238376920"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01548\">$Genscript Biotech(01548)$</a>Wooha!!&nbsp;","listText":"<a href=\"https://laohu8.com/S/01548\">$Genscript Biotech(01548)$</a>Wooha!!&nbsp;","text":"$Genscript Biotech(01548)$Wooha!!","images":[{"img":"https://static.tigerbbs.com/8f0d378e0571b77cb67d7fe59079a6e2","width":"1242","height":"1968"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690446344","isVote":1,"tweetType":1,"viewCount":2519,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":690498586,"gmtCreate":1639699367955,"gmtModify":1639699368017,"author":{"id":"4088854238376920","authorId":"4088854238376920","name":"ArigatoMoney","avatar":"https://static.tigerbbs.com/7fdd63d4d735e78c6522c3b0ca49b71d","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088854238376920","authorIdStr":"4088854238376920"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VZ\">$Verizon(VZ)$</a>Starting to increase. After a 2 weeks wait.","listText":"<a href=\"https://laohu8.com/S/VZ\">$Verizon(VZ)$</a>Starting to increase. After a 2 weeks wait.","text":"$Verizon(VZ)$Starting to increase. After a 2 weeks wait.","images":[{"img":"https://static.tigerbbs.com/7ac2258b79874eb78f953eaab5475bd9","width":"1125","height":"2984"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690498586","isVote":1,"tweetType":1,"viewCount":1053,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":840189342,"gmtCreate":1635605998907,"gmtModify":1635605998907,"author":{"id":"4088854238376920","authorId":"4088854238376920","name":"ArigatoMoney","avatar":"https://static.tigerbbs.com/7fdd63d4d735e78c6522c3b0ca49b71d","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088854238376920","authorIdStr":"4088854238376920"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CCL\">$Carnival(CCL)$</a>go go go…&nbsp;","listText":"<a href=\"https://laohu8.com/S/CCL\">$Carnival(CCL)$</a>go go go…&nbsp;","text":"$Carnival(CCL)$go go go…","images":[{"img":"https://static.tigerbbs.com/42a02abd970277c5dd377f141aeb691e","width":"1242","height":"1968"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/840189342","isVote":1,"tweetType":1,"viewCount":769,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":866841140,"gmtCreate":1632755984980,"gmtModify":1632798047936,"author":{"id":"4088854238376920","authorId":"4088854238376920","name":"ArigatoMoney","avatar":"https://static.tigerbbs.com/7fdd63d4d735e78c6522c3b0ca49b71d","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088854238376920","authorIdStr":"4088854238376920"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FUBO\">$fuboTV Inc.(FUBO)$</a>Go go go!&nbsp;","listText":"<a href=\"https://laohu8.com/S/FUBO\">$fuboTV Inc.(FUBO)$</a>Go go go!&nbsp;","text":"$fuboTV Inc.(FUBO)$Go go go!","images":[{"img":"https://static.tigerbbs.com/278934fbe9e29b8fac295bf96c18fa46","width":"1242","height":"1968"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/866841140","isVote":1,"tweetType":1,"viewCount":962,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":883250736,"gmtCreate":1631246873825,"gmtModify":1632883656907,"author":{"id":"4088854238376920","authorId":"4088854238376920","name":"ArigatoMoney","avatar":"https://static.tigerbbs.com/7fdd63d4d735e78c6522c3b0ca49b71d","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088854238376920","authorIdStr":"4088854238376920"},"themes":[],"htmlText":"[Miser]&nbsp;","listText":"[Miser]&nbsp;","text":"[Miser]","images":[{"img":"https://static.tigerbbs.com/c1d81f73c1a2f51e8378d1c31e8b34d7","width":"1125","height":"2879"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883250736","isVote":1,"tweetType":1,"viewCount":706,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":834249758,"gmtCreate":1629809877074,"gmtModify":1631885710494,"author":{"id":"4088854238376920","authorId":"4088854238376920","name":"ArigatoMoney","avatar":"https://static.tigerbbs.com/7fdd63d4d735e78c6522c3b0ca49b71d","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088854238376920","authorIdStr":"4088854238376920"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ADMP\">$Adamis Pharmaceuticals(ADMP)$</a>A friend recommended saying this may be good to buy now, and if FDA approves this home medication, it might increase. Bought it last friday. Any thoughts?&nbsp;","listText":"<a href=\"https://laohu8.com/S/ADMP\">$Adamis Pharmaceuticals(ADMP)$</a>A friend recommended saying this may be good to buy now, and if FDA approves this home medication, it might increase. Bought it last friday. Any thoughts?&nbsp;","text":"$Adamis Pharmaceuticals(ADMP)$A friend recommended saying this may be good to buy now, and if FDA approves this home medication, it might increase. Bought it last friday. Any thoughts?","images":[{"img":"https://static.tigerbbs.com/4cd5c494cf7ac18ba3ef466c1aa16f4c","width":"1242","height":"1767"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/834249758","isVote":1,"tweetType":1,"viewCount":1618,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3579824629573394","authorId":"3579824629573394","name":"股神lareina","avatar":"https://static.tigerbbs.com/7875819e7f109b6f0da66703f9a72051","crmLevel":2,"crmLevelSwitch":0,"idStr":"3579824629573394","authorIdStr":"3579824629573394"},"content":"only keep one day？","text":"only keep one day？","html":"only keep one day？"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":834249979,"gmtCreate":1629809771891,"gmtModify":1633682300721,"author":{"id":"4088854238376920","authorId":"4088854238376920","name":"ArigatoMoney","avatar":"https://static.tigerbbs.com/7fdd63d4d735e78c6522c3b0ca49b71d","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088854238376920","authorIdStr":"4088854238376920"},"themes":[],"htmlText":"Tempol a home covid medication that is on clinical trial, yet to be approved for use. Any thoughts?","listText":"Tempol a home covid medication that is on clinical trial, yet to be approved for use. Any thoughts?","text":"Tempol a home covid medication that is on clinical trial, yet to be approved for use. Any thoughts?","images":[{"img":"https://static.tigerbbs.com/36a32ed0bf7e7846cb83c9e2af5365a5","width":"1125","height":"3069"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/834249979","isVote":1,"tweetType":1,"viewCount":946,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":834265467,"gmtCreate":1629807884559,"gmtModify":1633682312983,"author":{"id":"4088854238376920","authorId":"4088854238376920","name":"ArigatoMoney","avatar":"https://static.tigerbbs.com/7fdd63d4d735e78c6522c3b0ca49b71d","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088854238376920","authorIdStr":"4088854238376920"},"themes":[],"title":"Advise for US stocks","htmlText":"https://youtube.com/channel/UC6hhtmnety48C4IbUo2GKWAThis guy is very good and give very good&nbsp;advise on stocks. He updates on a daily basis.&nbsp;","listText":"https://youtube.com/channel/UC6hhtmnety48C4IbUo2GKWAThis guy is very good and give very good&nbsp;advise on stocks. He updates on a daily basis.&nbsp;","text":"https://youtube.com/channel/UC6hhtmnety48C4IbUo2GKWAThis guy is very good and give very good advise on stocks. He updates on a daily basis.","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/834265467","isVote":1,"tweetType":1,"viewCount":1090,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":893294936,"gmtCreate":1628262955825,"gmtModify":1633752116232,"author":{"id":"4088854238376920","authorId":"4088854238376920","name":"ArigatoMoney","avatar":"https://static.tigerbbs.com/7fdd63d4d735e78c6522c3b0ca49b71d","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4088854238376920","authorIdStr":"4088854238376920"},"themes":[],"htmlText":"Now dropping… 🤦🏻‍♀️","listText":"Now dropping… 🤦🏻‍♀️","text":"Now dropping… 🤦🏻‍♀️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/893294936","repostId":"2157646054","repostType":4,"repost":{"id":"2157646054","kind":"highlight","pubTimestamp":1628255580,"share":"https://ttm.financial/m/news/2157646054?lang=&edition=full","pubTime":"2021-08-06 21:13","market":"us","language":"en","title":"Why COVID Vaccine Stocks Moderna, BioNTech, Novavax, and Dynavax Soared This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2157646054","media":"Motley Fool","summary":"Each vaccine stock had its own separate catalyst.","content":"<h3>What happened</h3>\n<p>Shares of several COVID-19 vaccine makers soared this week as of the market close on Thursday. <b>Novavax</b> (NASDAQ:NVAX) was the biggest winner, with its stock skyrocketing 31.7%. <b>BioNTech</b>'s (NASDAQ:BNTX) shares vaulted 23.3% higher. <b>Moderna</b> (NASDAQ:MRNA) stock jumped 17.7%. Shares of <b>Dynavax Technologies</b> (NASDAQ:DVAX) rose 10.6%.</p>\n<p>Was there a common denominator for all of these vaccine stocks? Increasing fears about the delta variant likely played a role to some extent. However, each company also had good news of its own.</p>\n<p><img src=\"https://static.tigerbbs.com/bcfbb91c5df631ab6670c1e77b9a0df3\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<p>Novavax announced on Wednesday that the European Commission agreed to purchase up to 200 million doses of its COVID-19 vaccine NVX-CoV2373. The deal includes an initial order of up to 100 million doses with an option to buy an additional 100 million doses through 2023.</p>\n<p>However, Novavax provided its second-quarter update following the market close on Thursday. The company now expects to file for Emergency Use Authorization (EUA) in the U.S. in the fourth quarter of 2021 instead of in the third quarter. Its shares gave up some of the week's gains in after-hours trading.</p>\n<p>BioNTech and its partner <b>Pfizer</b>&nbsp;benefited from a report that the U.S. Food and Drug Administration (FDA) will likely approve their COVID-19 vaccine by early September. <i>The New York Times</i> stated that the expected FDA approval could spur more vaccine mandates by employers.</p>\n<p>Moderna announced on Tuesday that it had received FDA Fast Track Designation for its respiratory syncytial virus (RSV) vaccine candidate mRNA-1345. The company also reported strong second-quarter results on Thursday and projected vaccine sales of $20 billion for the full year.</p>\n<p>Dynavax reported positive Q2 results on Wednesday. The company's revenue of $52.8 million blew past the consensus estimate of $41.6 million.</p>\n<h3>So what</h3>\n<p>Novavax had the biggest news of these vaccine makers. The company's European deal could generate a hefty amount of additional revenue over the next couple of years.</p>\n<p>Of the two companies reporting quarterly results, Dynavax delivered the greater upside surprise. Its Heplisav-B hepatitis B vaccine raked in $13.7 million in sales, the highest quarterly figure so far.</p>\n<p>Moderna also beat expectations with Q2 revenue of $4.4 billion. Arguably the most important update from the company, though, was that it has already secured supply deals for 2022 totaling $12 billion plus options for another $8 billion.</p>\n<p>The report about a potential quick FDA approval for the Pfizer-BioNTech vaccine lit a fire beneath BioNTech stock. However, this really wasn't surprising.</p>\n<h3>Now what</h3>\n<p>All four companies could have more good news on the way. Novavax is working to file for Emergency Use Authorization for its COVID-19 vaccine candidate by the end of the third quarter in the U.K. and, as previously mentioned, in Q4 in the U.S. Dynavax expects key data readouts this year from several partners who are using its CpG 1018 adjuvant with their experimental COVID-19 vaccines.</p>\n<p>Both BioNTech and Moderna hope to win full FDA approval for their respective COVID-19 vaccines. The companies are also angling to line up more supply deals for 2022 and beyond.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why COVID Vaccine Stocks Moderna, BioNTech, Novavax, and Dynavax Soared This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy COVID Vaccine Stocks Moderna, BioNTech, Novavax, and Dynavax Soared This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-06 21:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/06/why-covid-vaccine-stocks-moderna-biontech-novavax/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What happened\nShares of several COVID-19 vaccine makers soared this week as of the market close on Thursday. Novavax (NASDAQ:NVAX) was the biggest winner, with its stock skyrocketing 31.7%. BioNTech's...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/06/why-covid-vaccine-stocks-moderna-biontech-novavax/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","DVAX":"德纳维制药","MRNA":"Moderna, Inc.","NVAX":"诺瓦瓦克斯医药"},"source_url":"https://www.fool.com/investing/2021/08/06/why-covid-vaccine-stocks-moderna-biontech-novavax/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2157646054","content_text":"What happened\nShares of several COVID-19 vaccine makers soared this week as of the market close on Thursday. Novavax (NASDAQ:NVAX) was the biggest winner, with its stock skyrocketing 31.7%. BioNTech's (NASDAQ:BNTX) shares vaulted 23.3% higher. Moderna (NASDAQ:MRNA) stock jumped 17.7%. Shares of Dynavax Technologies (NASDAQ:DVAX) rose 10.6%.\nWas there a common denominator for all of these vaccine stocks? Increasing fears about the delta variant likely played a role to some extent. However, each company also had good news of its own.\n\nImage source: Getty Images.\nNovavax announced on Wednesday that the European Commission agreed to purchase up to 200 million doses of its COVID-19 vaccine NVX-CoV2373. The deal includes an initial order of up to 100 million doses with an option to buy an additional 100 million doses through 2023.\nHowever, Novavax provided its second-quarter update following the market close on Thursday. The company now expects to file for Emergency Use Authorization (EUA) in the U.S. in the fourth quarter of 2021 instead of in the third quarter. Its shares gave up some of the week's gains in after-hours trading.\nBioNTech and its partner Pfizer benefited from a report that the U.S. Food and Drug Administration (FDA) will likely approve their COVID-19 vaccine by early September. The New York Times stated that the expected FDA approval could spur more vaccine mandates by employers.\nModerna announced on Tuesday that it had received FDA Fast Track Designation for its respiratory syncytial virus (RSV) vaccine candidate mRNA-1345. The company also reported strong second-quarter results on Thursday and projected vaccine sales of $20 billion for the full year.\nDynavax reported positive Q2 results on Wednesday. The company's revenue of $52.8 million blew past the consensus estimate of $41.6 million.\nSo what\nNovavax had the biggest news of these vaccine makers. The company's European deal could generate a hefty amount of additional revenue over the next couple of years.\nOf the two companies reporting quarterly results, Dynavax delivered the greater upside surprise. Its Heplisav-B hepatitis B vaccine raked in $13.7 million in sales, the highest quarterly figure so far.\nModerna also beat expectations with Q2 revenue of $4.4 billion. Arguably the most important update from the company, though, was that it has already secured supply deals for 2022 totaling $12 billion plus options for another $8 billion.\nThe report about a potential quick FDA approval for the Pfizer-BioNTech vaccine lit a fire beneath BioNTech stock. However, this really wasn't surprising.\nNow what\nAll four companies could have more good news on the way. Novavax is working to file for Emergency Use Authorization for its COVID-19 vaccine candidate by the end of the third quarter in the U.K. and, as previously mentioned, in Q4 in the U.S. Dynavax expects key data readouts this year from several partners who are using its CpG 1018 adjuvant with their experimental COVID-19 vaccines.\nBoth BioNTech and Moderna hope to win full FDA approval for their respective COVID-19 vaccines. The companies are also angling to line up more supply deals for 2022 and beyond.","news_type":1,"symbols_score_info":{"BNTX":0.9,"DVAX":0.9,"MRNA":0.9,"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":773,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"followers","isTTM":false}